C
APGE icon

Covestor’s Apogee Therapeutics APGE Stock Holding History

Covestor’s Portfolio APGE Stock Details APGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$0 Hold
2
– – ﹤0.01% 2230
2025
Q4 		$0 Sell
2
-1
-33% -$63 ﹤0.01% 2237
2025
Q3 		$0 Hold
3
– – ﹤0.01% 2249
2025
Q2 		$0 Hold
3
– – ﹤0.01% 2172
2025
Q1 		$0 Hold
3
– – ﹤0.01% 2182
2024
Q4 		$0 Hold
3
– – ﹤0.01% 2200
2024
Q3 		$0 Hold
3
– – ﹤0.01% 2178
2024
Q2 		$0 Hold
3
– – ﹤0.01% 2211
2024
Q1 		$0 Buy
+3
New +$131 ﹤0.01% 2202

Other funds holding APGE

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Covestor's APGE Position: Q1 2026 in Review

Covestor held its Apogee Therapeutics (APGE) position steady in Q1 2026 at 2 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2230.

Covestor first reported a position in APGE in Q1 2024 and has held it in 9 quarters since. 224 funds tracked by Wall St. Rank hold APGE as of Q1 2026.

  • Covestor held 2 shares of Apogee Therapeutics worth $0 as of Q1 2026.
  • Covestor left its Apogee Therapeutics share count unchanged in Q1 2026.
  • Apogee Therapeutics made up ﹤0.01% of Covestor's portfolio in Q1 2026, its #2230 holding.
  • Covestor first reported a position in Apogee Therapeutics in Q1 2024 and has held it in 9 quarters since.
  • 224 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q1 2026.

Based on Covestor's 13F filing for Q1 2026, filed 5 May 2026.